Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 16, 2012
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - Market Wire
[ Mon, Jul 16th 2012
] - Market Wire
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
Edward Tenthoff Maintained (ALNY) at Buy with Increased Target to $20 on, Jul 16th, 2012
Edward Tenthoff of Piper Sandler, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $17 to $20 on, Jul 16th, 2012.
Edward has made no other calls on ALNY in the last 4 months.
There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $15 on, Tuesday, May 8th, 2012
Similar Stocks and Investing Articles
[ Fri, Jul 06th 2012
] - WOPRAI
[ Wed, May 23rd 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Fri, Apr 27th 2012
] - WOPRAI
[ Wed, Apr 25th 2012
] - WOPRAI
[ Wed, Apr 11th 2012
] - WOPRAI
[ Tue, Mar 27th 2012
] - WOPRAI
[ Fri, Mar 16th 2012
] - WOPRAI
[ Tue, Mar 06th 2012
] - WOPRAI